DLin-MC3-DMA
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
XH-07 is an ionizable cationic lipid reported as the lipid carrier in JCXH-211, an experimental IL-12 RNA lipid nanoparticle formulation studied in preclinical cancer models. The published work describes cellular IL-12 expression, antitumor responses and exploratory tolerability observations for the complete formulation. XH-07 is supplied as a research reagent; these findings do not establish the activity or safety of the isolated lipid, or equivalent results with other RNA cargoes.
| CAS No. | Not available |
| Chemical Name | XH-07 |
| Synonyms | XH07;XH 07 |
| SMILES | CCCCCCCCCOC(=O)CCCCCCCOC1=CC=C(OCCCCCCCC(=O)OC(CCCCCCCC)CCCCCCCC)C=C1COC(=O)CCCN(C)C |
| Formula | C55H99O8N |
| M.Wt | 902.40 |
| Purity | >98% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Wang et al., Scientific Reports 14, 7366 (2024) |
Published evidence for XH-07 as the carrier lipid in JCXH-211.
The biological results belong to the complete RNA–LNP formulation, not to isolated XH-07.
Read the full literature analysis →
| Reported attribute | Result | Interpretation / source |
|---|---|---|
| Mean particle diameter | Approximately 80 nm | Complete formulated particles, not a specification of neat XH-07. Main article, Methods; Supplementary Fig. 1. |
| Polydispersity index | 0.07–0.16 | Reported formulation characterization range; not a guaranteed lot-release range for the supplied lipid. Main article, Methods. |
| RNA encapsulation | Above 85% | Reported for the complete formulation. Main article, Methods. |
| Zeta potential | Distribution shown in Supplementary Fig. 1B | The previous catalog value is not used as a universal or independently verified specification. |
Wang Z, Chen Y, Wu H, et al. Intravenous administration of IL-12 encoding self-replicating RNA-lipid nanoparticle complex leads to safe and effective antitumor responses. Scientific Reports 14, 7366 (2024). doi:10.1038/s41598-024-57997-w. Main article and accompanying Supplementary Material reviewed.
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 11.0816 mL | 2.2163 mL | 1.1082 mL |
| 25 mg | 27.7039 mL | 5.5408 mL | 2.7704 mL |
| 50 mg | 55.4078 mL | 11.0816 mL | 5.5408 mL |
| 100 mg | 110.8156 mL | 22.1631 mL | 11.0816 mL |
| 250 mg | 277.0390 mL | 55.4078 mL | 27.7039 mL |
Contact our team with the catalog number and requested quantity.